Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Schell

Showing results (591-600 of 634) with videos related to

Pageof 64
Sort By:
Research Square|July 29, 2024
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Biological Research for Nursing|January 31, 2014
Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patientsRichard R Reich, Cecile A Lengacher, Kevin E Kip, et al.
Contemporary Clinical Trials|March 4, 2026
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center Clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasiaK A Keefe, M J Schell, C Brewer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemiaDouglas K Graham, Dana B Salzberg, Joanne Kurtzberg, et al.
Science (New York, N.Y.)|January 4, 2024
Biodiversity monitoring for a just planetary futureMelissa Chapman, Benjamin R Goldstein, Christopher J Schell, et al.
Emerging Infectious Diseases|January 26, 2022
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021Anna R Giuliano, Shari Pilon-Thomas, Michael J Schell, et al.
Journal for Immunotherapy of Cancer|June 8, 2022
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinomaXuefeng Wang, Jameel Muzaffar, Kedar Kirtane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanomaGeoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, et al.
Pageof 64

Showing results (591-600 of 634) with videos related to

Sort By:
Pageof 64
Research Square|July 29, 2024
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Biological Research for Nursing|January 31, 2014
Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patientsRichard R Reich, Cecile A Lengacher, Kevin E Kip, et al.
Contemporary Clinical Trials|March 4, 2026
Protocol paper for an implementation science approach to promoting colorectal cancer screening in Federally Qualified Health Center Clinics: A stepped-wedge, multilevel intervention trialSamantha M Montoya, Pelumi Olaore, Janna Bastardo-Acosta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 6, 2001
A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasiaK A Keefe, M J Schell, C Brewer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancerCraig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemiaDouglas K Graham, Dana B Salzberg, Joanne Kurtzberg, et al.
Science (New York, N.Y.)|January 4, 2024
Biodiversity monitoring for a just planetary futureMelissa Chapman, Benjamin R Goldstein, Christopher J Schell, et al.
Emerging Infectious Diseases|January 26, 2022
SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021Anna R Giuliano, Shari Pilon-Thomas, Michael J Schell, et al.
Journal for Immunotherapy of Cancer|June 8, 2022
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinomaXuefeng Wang, Jameel Muzaffar, Kedar Kirtane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanomaGeoffrey T Gibney, Ragini R Kudchadkar, Ronald C DeConti, et al.
Pageof 64